Alpha Synuclein N-Terminal Acetylated Monomers (Type 1)

CAT:
400-SPR-331C
Size:
2x 100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: Yes
Alpha Synuclein N-Terminal Acetylated Monomers (Type 1) - image 1
Alpha Synuclein N-Terminal Acetylated Monomers (Type 1) - image 2
Alpha Synuclein N-Terminal Acetylated Monomers (Type 1) - image 3
Thumbnail 1
Thumbnail 2
Thumbnail 3

Alpha Synuclein N-Terminal Acetylated Monomers (Type 1)

  • Background:

    Alpha-Synuclein (SNCA) is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals (1). Alpha-synuclein is highly expressed in the mitochondria of the olfactory bulb, hippocampus, striatum and thalamus (2). Functionally, it has been shown to significantly interact with tubulin (3), and may serve as a potential microtubule-associated protein. It has also been found to be essential for normal development of the cognitive functions; inactivation may lead to impaired spatial learning and working memory (4). SNCA fibrillar aggregates represent the major non A-beta component of Alzheimers disease amyloid plaque, and a major component of Lewy body inclusions, and Parkinson's disease. Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin (5, 6). Alpha synuclein purified from both normal and pathological brain tissue is N-acetylated (7) and this post-translational modification affects affect alpha-synuclein stability and toxicity (8).
  • Description:

    Human Recombinant N-Terminal Acetylated Alpha Synuclein Monomers (Type 1)
  • Product Name Alternative:

    N-acetylated Alpha synuclein monomer, N-terminal acetylated Alpha-synuclein monomer, Alpha synuclein protein monomer, Alpha synuclein monomer, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, Alpha synuclein monomers, SYN protein, Parkinson's disease familial 1 Protein, N‐terminal Ac‐αsyn
  • UNSPSC:

    12352202
  • Gene ID:

    6622
  • Swiss Prot:

    P37840
  • Accession Number:

    NP_000336.1
  • Cellular Locus:

    Cytoplasm | Membrane | Nucleus
  • Host:

    E. coli
  • Origin Species:

    Human
  • Target:

    Alpha Synuclein N-Terminal Acetylated
  • Conjugation:

    No Tag
  • Applications:

    WB, SDS-PAGE, In vivo assay, In vitro assay
  • Purification Method:

    Ion-exchange Purified
  • Concentration:

    2 mg/ml
  • Purity:

    >95%
  • Activity:

    Seeds aggregation of N-acetylated alpha synuclein monomer (SPR-331) in thioflavin T assay
  • Weight:

    0.02
  • Length:

    Full Length
  • Buffer:

    PBS pH 7.4
  • Molecular Weight:

    ~14.46kDa
  • Precautions:

    Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.
  • Additionnal Information:

    For corresponding PFFs, see catalog# SPR-332
  • References & Citations:

    1. “Genetics Home Reference: SNCA”. US National Library of Medicine. (2013). 2. Zhang L., et al. (2008) Brain Res. 1244: 40-52. 3. Alim M.A., et al. (2002) J Biol Chem. 277(3): 2112-2117. 4. Kokhan V.S., Afanasyeva M.A., Van'kin G. (2012) Behav. Brain. Res. 231(1): 226-230. 5. Spillantini M.G., et al. (1997) Nature. 388(6645): 839-840. 6. Mezey E., et al. (1998) Nat Med. 4(7): 755-757. 7. Anderson, J.P. et al. (2006) J Biol Chem. 2006;281:29739–29752. 8. Vinueza-Gavilanes, R. et al. (2020) Neurobiol Dis. 137, 2020, Article 104783

MSDS

MSDS Document

View Document